Literature DB >> 1314467

Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody.

R L Ward1, M M McNeal, J F Sheridan.   

Abstract

Studies were performed to determine whether active immunity against murine rotavirus (EDIM) infection of mice correlated with titers of neutralizing antibody to the challenge virus. Neonatal mice administered either murine or heterologous rotaviruses all developed diarrhea and high titers of serum rotavirus IgG. However, only mice given EDIM, the murine EB, or simian SA11-FEM strains were protected against EDIM infection when challenged 60 days later. Other serotype 3 strains (RRV, SA11-SEM), as well as strains belonging to serotypes 5 and 6 (OSU, NCDV, WC3), were not protective. Serum neutralizing antibody titers to EDIM were almost undetectable after rotavirus infection with any strain and could not, therefore, be correlated with protection. Likewise, intestinal neutralizing antibody titers were extremely low 21 days after EDIM infection, and by 60 days after inoculation, EDIM-infected mice had no greater intestinal neutralizing antibody titers than uninoculated controls. Mice inoculated with SA11-FEM as neonates had much higher serum rotavirus IgG responses than mice inoculated as adults, and only those infected with this virus as neonates were protected. Thus, although immunity to EDIM did not correlate with the presence of neutralizing antibody to EDIM, it did correlate with the overall magnitude of the immune response after inoculation with SA11-FEM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314467     DOI: 10.1016/0042-6822(92)90734-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Abdul Rauf; Stephanie N Langel; David E Wentworth; Karla M Stucker; Rebecca A Halpin; Ham Ching Lam; Douglas Marthaler; Linda J Saif; Anastasia N Vlasova
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

Authors:  L Yuan; L A Ward; B I Rosen; T L To; L J Saif
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.

Authors:  Esmeralda Vizzi; Eva Calviño; Rosabel González; Irene Pérez-Schael; Max Ciarlet; Gagandeep Kang; Mary K Estes; Ferdinando Liprandi; Juan E Ludert
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

6.  Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection.

Authors:  Max Ciarlet; Margaret E Conner; Milton J Finegold; Mary K Estes
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.

Authors:  Paula M Hertel; Sue E Crawford; Brooke C Bessard; Mary K Estes
Journal:  Vaccine       Date:  2013-07-22       Impact factor: 3.641

8.  Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

Authors:  Ningguo Feng; Jeffrey A Lawton; Joana Gilbert; Nelly Kuklin; Phuoc Vo; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

9.  Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique.

Authors:  S C Richardson; K Grimwood; R F Bishop
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.

Authors:  R L Ward; M M McNeal; D S Sander; H B Greenberg; D I Bernstein
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.